Cargando…
Uses and Challenges of Antiviral Polyclonal and Monoclonal Antibody Therapies
Viral diseases represent a major public health concerns and ever-present risks for developing into future pandemics. Antiviral antibody therapeutics, either alone or in combination with other therapies, emerged as valuable preventative and treatment options, including during global emergencies. Here...
Autores principales: | Struble, Evi B., Rawson, Jonathan M. O., Stantchev, Tzanko, Scott, Dorothy, Shapiro, Marjorie A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10224075/ https://www.ncbi.nlm.nih.gov/pubmed/37242780 http://dx.doi.org/10.3390/pharmaceutics15051538 |
Ejemplares similares
-
Passive Monoclonal and Polyclonal Antibody Therapies
por: Pelletier, J. Peter R., et al.
Publicado: (2020) -
Monoclonal and Polyclonal Antibodies Specific to Human Fibromodulin
por: Farahi, Lia, et al.
Publicado: (2019) -
Antibodies in infectious diseases: polyclonals, monoclonals and niche biotechnology
por: Berry, Jody D., et al.
Publicado: (2011) -
Challenges and opportunities for antiviral monoclonal antibodies as COVID-19 therapy
por: Cruz-Teran, Carlos, et al.
Publicado: (2021) -
Production and application of polyclonal and monoclonal antibodies against Spiroplasma eriocheiris
por: Zhang, Ying, et al.
Publicado: (2015)